Rani Therapeutics Holdings (RANI) Earnings Analysis

Rani Therapeutics Holdings (RANI) next reports earnings on 2026-08-06, consensus EPS -0.05 USD. Last quarter (2026-05-15) it beat with EPS -0.04 USD vs -0.06 USD est (+33.3%). It has beaten estimates in 2/6 recent quarters (33%). Trailing P/E -2.19.

Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades

When does RANI next report earnings?

Next earnings date2026-08-06
Consensus EPS estimate-0.05 USD
Revenue estimate0.00B

RANI earnings history — beats and misses

Quarter (report date)EPS actualEPS est.SurpriseResult
2026-05-15-0.04 USD-0.06 USD+33.3%Beat
2026-03-26-0.07 USD-0.03 USD-133.3%Miss
2025-11-06-0.12 USD-0.09 USD-33.3%Miss
2025-08-07-0.18 USD-0.19 USD+5.3%Beat
2025-03-31-0.27 USD-0.24 USD-12.5%Miss
2024-11-14-0.24 USD-0.22 USD-9.1%Miss

Beat rate: 2/6 (33%) over reported quarters with consensus data.

RANI valuation and analyst view

Trailing P/E-2.19
Trailing EPS-0.16357 USD
Price / book5.68
Dividend yield0.00%
Market cap0.06B
Analyst consensusBuy (7 buy / 0 hold / 0 sell)

Related research pages

Frequently asked questions

When is Rani Therapeutics Holdings (RANI)'s next earnings date?

Rani Therapeutics Holdings is next scheduled to report on 2026-08-06, with a consensus EPS estimate of -0.05 USD and revenue estimate of 0.00B.

Did RANI beat earnings last quarter?

In its 2026-05-15 report, RANI posted EPS of -0.04 USD versus a -0.06 USD estimate — a beat of 33.3%.

What is RANI's earnings track record?

Over the last 6 reported quarters with consensus data, RANI beat estimates 2 times (33%).

What is RANI's current P/E ratio and EPS?

RANI trades at a trailing P/E of -2.19 on trailing EPS of -0.16357030156225694 USD.

What do analysts rate RANI?

Analyst consensus is "Buy" across 7 ratings (0 strong buy, 7 buy, 0 hold, 0 sell, 0 strong sell).